Skip to main content

๐™‹๐™–๐™ง๐™ฉ 1 โ€” ๐™๐™๐™š ๐˜ฝ๐™ง๐™ค๐™ ๐™š๐™ฃ ๐™€๐™˜๐™ค๐™ฃ๐™ค๐™ข๐™ž๐™˜๐™จ ๐™ค๐™› ๐™‹๐™ค๐™ฅ๐™ช๐™ก๐™–๐™ฉ๐™ž๐™ค๐™ฃ ๐™ƒ๐™š๐™–๐™ก๐™ฉ๐™ (๐™–๐™ฃ๐™™ ๐™’๐™๐™ฎ ๐˜พ๐™๐™–๐™จ๐™ž๐™ฃ๐™œ ๐˜ฟ๐™š๐™ข๐™–๐™ฃ๐™™ ๐™ƒ๐™–๐™จ ๐™‡๐™š๐™™ ๐™ฉ๐™ค ๐™ˆ๐™–๐™ง๐™œ๐™ž๐™ฃ ๐™€๐™ง๐™ค๐™จ๐™ž๐™ค๐™ฃ)

For more than a decade, population health management has been the rallying cry of U.S. healthcare. Health plans, providers, and consultants promised that better care coordination, care gap closure, and value-based care programs would finally bend the cost curve. Billions of dollars were poured into care management platforms, member engagement apps, and utilization management programs.

And yet, the numbers tell a different story:

โ€ข Administrative costs for commercial health plans remain in the 12โ€“15% range, while traditional Medicare runs at ~2%.

โ€ข Medical Loss Ratios (MLR) in Medicare Advantage and Medicaid managed care continue to fluctuate under pressure, forcing payers to chase Stars Ratings, Quality Bonus Payments (QBP), and risk adjustment revenue just to maintain margins.

The uncomfortable truth: what weโ€™ve called โ€œpopulation health economicsโ€ has really been demand-side economics in disguise.

๐™’๐™๐™ฎ ๐˜ฟ๐™š๐™ข๐™–๐™ฃ๐™™โ€“๐™Ž๐™ž๐™™๐™š ๐™๐™๐™ž๐™ฃ๐™ ๐™ž๐™ฃ๐™œ ๐™๐™–๐™ž๐™ก๐™จ

Demand-side economics in healthcare looks like this:

โ€ข Waiting for claims data (180-day lag) to identify risk.

โ€ข Suppressing demand with narrow networks and high deductibles.

โ€ข Rationing utilization through prior authorization and denials.

โ€ข Obsessing over gap closure as the pathway to quality scores.

This creates an illusion of control but it doesnโ€™t scale. Instead, it produces margin erosion:

โ€ข Every care gap closed reopens again next year.

โ€ข Utilization suppression backfires as members delay care and return sicker, costlier, and angrier.

โ€ข Care management programs collapse under workforce strain, with case managers overloaded and burnout rising.

โ€ข Tech point-solutions fail to bend MLR because they werenโ€™t designed for systemic economics.

The result? Payers are stuck on a treadmill. Margins erode, member experience suffers, and executives keep paying consultants for strategies that only rearrange demand-side data.

๐—” ๐—ฃ๐—ผ๐—น๐—ฎ๐—ฟ๐—ถ๐˜‡๐—ถ๐—ป๐—ด ๐—•๐˜‚๐˜ ๐—ก๐—ฒ๐—ฐ๐—ฒ๐˜€๐˜€๐—ฎ๐—ฟ๐˜† ๐—ฃ๐—ผ๐—ถ๐—ป๐˜

Hereโ€™s where this gets uncomfortable for many in the industry:

If youโ€™ve been relying on claims-driven insights, retrospective care gap closure, or point-solution โ€œengagement tools,โ€ you havenโ€™t been doing population health economics. ๐šˆฬฒ๐š˜ฬฒ๐šžฬฒโ€™ฬฒ๐šŸฬฒ๐šŽฬฒโ€€ฬฒ๐š‹ฬฒ๐šŽฬฒ๐šŽฬฒ๐š—ฬฒโ€€ฬฒ๐šฬฒ๐š˜ฬฒ๐š’ฬฒ๐š—ฬฒ๐šฬฒโ€€ฬฒ๐š™ฬฒ๐š˜ฬฒ๐š™ฬฒ๐šžฬฒ๐š•ฬฒ๐šŠฬฒ๐šฬฒ๐š’ฬฒ๐š˜ฬฒ๐š—ฬฒโ€€ฬฒ๐š‘ฬฒ๐šŽฬฒ๐šŠฬฒ๐š•ฬฒ๐šฬฒ๐š‘ฬฒโ€€ฬฒ๐šŠฬฒ๐šŒฬฒ๐šŒฬฒ๐š˜ฬฒ๐šžฬฒ๐š—ฬฒ๐šฬฒ๐š’ฬฒ๐š—ฬฒ๐šฬฒ.ฬฒ

That accounting has delivered no lasting margin stability, no reduction in avoidable utilization, and no real progress toward equity.

Medicare Advantage margins are under pressure not because CMS made the Stars cut harder, but because Stars themselves were never the real lever of population health economics.

Plans spent a decade engineering โ€œgap-chasingโ€ and quality performance infrastructure, only to discover that when CMS adjusted the scoring curve, the entire house of cards collapsed. Billions in admin and vendor spend, yet no durable economics.

This is the core failure of demand-side thinking: building systems to optimize scores instead of creating new inputs. When the scoring rubric shifts, demand-side economics implodes. Supply-side economics doesnโ€™t depend on CMS formulas it generates continuous, member-driven risk data that stabilizes MLR whether Stars are up, down, or rewritten.

Health plans were never built as supply-side engines.

โ€ข They donโ€™t deliver care โ€” they administer access.

โ€ข They donโ€™t generate new inputs โ€” they ration existing ones.

โ€ข They donโ€™t create visibility โ€” they price networks and report lagging claims.

Thatโ€™s why supply-side economics has escaped them. It never fit their operating model. Instead, they built a decade of infrastructure around demand-side levers: utilization controls, Stars gap-chasing, risk adjustment coding.

And when CMS shifted the Star Ratings curve, the whole faรงade cracked. Billions in administrative spend collapsed into a hamster wheel that never produced durable economics.

But hereโ€™s the real pivot: supply-side economics doesnโ€™t ignore CMS rubrics. It renders them irrelevant as constraints because when you generate a continuous supply of member-driven risk data, you always have the inputs to dominate any scoring system Washington creates, today or tomorrow.

Thatโ€™s the difference: demand-side plans try to โ€œgameโ€ CMS rules. Supply-side plans set themselves up to win no matter how the rules change.

Demand-side tools donโ€™t solve the problem they only document it.

๐—ง๐—ต๐—ฒ ๐—ฆ๐—ต๐—ถ๐—ณ๐˜ ๐—”๐—ต๐—ฒ๐—ฎ๐—ฑ

If the last decade of โ€œpopulation health managementโ€ has proven anything, itโ€™s this:

โ€ข You canโ€™t close your way to profitability.

โ€ข You canโ€™t suppress your way to sustainability.

โ€ข And you canโ€™t consult your way into new data supply.

The broken economics of population health is the failure to recognize that no amount of demand-side tinkering can stabilize payer margins. Whatโ€™s needed is a supply-side engine a scalable, continuous stream of real-time risk data that creates new inputs into the system.

Part 1 of 10.

Contact Us

Better health outcomes are possible. Letโ€™s talk about how MyRoad.io can help you achieve them.

Name*(Required)